🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 603170101
- Market Cap
- Mid Cap
- IPO
- 2/10/2023 · $16.00/share
Business: Mineralys Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone.
Company Contact
- CEO
- Jon Congleton
- CFO
- Adam Levy
- Headquarters
- 150 N. Radnor Chester Road, Suite F200, Radnor, PA 19087
- Phone
- 888-378-6240 · Toll-Free 888-378-6240
- Investor Relations
- investorrelations@mineralystx.com